Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
23.29
+0.45 (1.97%)
Nov 5, 2024, 4:00 PM EST - Market closed
Viridian Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | -228.06 | -237.73 | -129.87 | -79.41 | -110.72 | -41.87 | Upgrade
|
Depreciation & Amortization | 0.57 | 0.52 | 0.26 | 0.12 | 0.24 | 0.29 | Upgrade
|
Other Amortization | - | - | - | - | 0.28 | - | Upgrade
|
Loss (Gain) From Sale of Assets | 0 | 0 | - | 0.08 | - | - | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | - | - | 65.99 | - | Upgrade
|
Loss (Gain) From Sale of Investments | -14.68 | -11.49 | -0.21 | 0.96 | 0.06 | -0.43 | Upgrade
|
Stock-Based Compensation | 64.11 | 67.17 | 19.77 | 14.47 | 3.65 | 3.97 | Upgrade
|
Other Operating Activities | 2.08 | 6.78 | 0.26 | 7.49 | 6.3 | 0.34 | Upgrade
|
Change in Accounts Receivable | 0.1 | - | 0.35 | -0.45 | - | -0.08 | Upgrade
|
Change in Accounts Payable | -0.7 | -12.04 | 11.52 | 1.66 | -0.43 | 0.53 | Upgrade
|
Change in Unearned Revenue | -0.29 | -0.29 | -0.29 | 0.64 | - | - | Upgrade
|
Change in Other Net Operating Assets | 8.59 | 2.9 | 4.38 | -0.12 | 4.85 | 1.21 | Upgrade
|
Operating Cash Flow | -168.26 | -184.17 | -93.84 | -54.58 | -29.78 | -36.06 | Upgrade
|
Capital Expenditures | -0.56 | -0.9 | -0.8 | -0.34 | -0.04 | -0.08 | Upgrade
|
Sale of Property, Plant & Equipment | - | - | - | 0.08 | - | - | Upgrade
|
Cash Acquisitions | - | - | - | - | 29.37 | - | Upgrade
|
Investment in Securities | -202.18 | -93.35 | -114.33 | -74.03 | -79.81 | 28.31 | Upgrade
|
Other Investing Activities | - | - | - | - | -0 | - | Upgrade
|
Investing Cash Flow | -202.74 | -94.25 | -115.13 | -74.29 | -50.48 | 28.23 | Upgrade
|
Long-Term Debt Issued | - | 15 | 5 | - | 1.73 | - | Upgrade
|
Total Debt Issued | 15 | 15 | 5 | - | 1.73 | - | Upgrade
|
Long-Term Debt Repaid | - | - | - | - | -10.29 | -2.33 | Upgrade
|
Net Debt Issued (Repaid) | 15 | 15 | 5 | - | -8.57 | -2.33 | Upgrade
|
Issuance of Common Stock | 323.19 | 146.79 | 295.75 | 116.59 | 25.1 | 2.48 | Upgrade
|
Repurchase of Common Stock | - | - | - | - | -0.04 | - | Upgrade
|
Other Financing Activities | -22.79 | -12.32 | -22.51 | -8.28 | -6.18 | -0.08 | Upgrade
|
Financing Cash Flow | 391.59 | 225.67 | 322.24 | 125.28 | 101.31 | 0.07 | Upgrade
|
Net Cash Flow | 20.59 | -52.75 | 113.28 | -3.6 | 21.05 | -7.76 | Upgrade
|
Free Cash Flow | -168.82 | -185.07 | -94.64 | -54.92 | -29.82 | -36.14 | Upgrade
|
Free Cash Flow Margin | -58618.06% | -58938.85% | -5340.58% | -1853.49% | -2840.10% | -810.13% | Upgrade
|
Free Cash Flow Per Share | -3.09 | -4.14 | -2.95 | -4.61 | -8.38 | -17.30 | Upgrade
|
Cash Interest Paid | 1.57 | 0.89 | 0.29 | - | 0.27 | 0.51 | Upgrade
|
Levered Free Cash Flow | -87.13 | -102.82 | -48.83 | -33.91 | -16.58 | -19.57 | Upgrade
|
Unlevered Free Cash Flow | -85.44 | -101.66 | -48.52 | -33.91 | -16.55 | -19.05 | Upgrade
|
Change in Net Working Capital | -7.18 | 9.43 | -16.2 | -1.67 | -4.94 | -1.76 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.